Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-19
1996-04-02
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540225, C07D50157, A61K 31545
Patent
active
055040764
ABSTRACT:
7.beta.- 2-(aminothiazolyl and thiadiazolyl)-2-oxyiminoacetamido!cephalosporin derivatives having a 3- N-(optionally substituted) aminopyridiniumthiomethyl! substituent have antibacterial activity and are of use in antibacterial therapy. Processes for the preparation of such cephalosporins plus intermediates for use in the preparation thereof, including N-(optionally substituted)amino-thiopyridones, are also described.
REFERENCES:
patent: 4785090 (1988-11-01), Tsursoka et al.
patent: 4786633 (1988-11-01), Wagatsuma et al.
patent: 4971963 (1990-11-01), Sendai et al.
patent: 5008260 (1991-04-01), Yamauchi et al.
patent: 5173485 (1992-12-01), Sakane et al.
patent: 5275816 (1994-01-01), Branch et al.
patent: 5336673 (1994-08-01), Man et al.
Journal of Heterocyclic Chemistry, vol. 11, No. 4, Aug. 1974, Action of Amines and Carbonyl Reagents on 3,5-Diphenyl-4-pyrone and its Thio . . . pp. 487-490.
Bulletin of the chemical Society of Japan, vol. 51, 1978, Reactions of 4H-Pyran-4-thiones with Ammonia, Hydrazine and Guanidine, pp. 179-181.
Journal of the Chemical Society, 1977, Preparation of NN'-Linked Bi(heteroaryls) from Dehydroacetic Acid and 2, 6-Dimethyl-4-pyrone, pp. 1428-1436.
Adams Richard G.
Branch Clive L.
Guest Angela W.
Ginsburg Paul H.
Ling Lorraine B.
Pfizer Inc.
Richardson Peter C.
Rizzo Nicholas
LandOfFree
Cephalosporin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephalosporin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016426